Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

Karin Melanie Cabanillas Stanchi,1,* Semjon Willier,2,* Julia Vek,1 Patrick Schlegel,1 Manon Queudeville,1 Nora Rieflin,1 Veronika Klaus,1 Melanie Gansel,1 Joachim Vincent Rupprecht,1 Tim Flaadt,1 Vera Binder,2 Tobias Feuchtinger,2 Peter Lang,1 Rupert Handgretinger,1 Michaela Döring1 1Depar...

Full description

Bibliographic Details
Main Authors: Cabanillas Stanchi KM, Willier S, Vek J, Schlegel P, Queudeville M, Rieflin N, Klaus V, Gansel M, Rupprecht JV, Flaadt T, Binder V, Feuchtinger T, Lang P, Handgretinger R, Döring M
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Drug Design, Development and Therapy
Subjects:
fosaprepitant
5-ht3-antagonists
pediatric
antiemetic prophylaxis
chemotherapy induced nausea and vomiting
autologous hematopoietic stem cell transplantation
Online Access:https://www.dovepress.com/antiemetic-prophylaxis-with-fosaprepitant-and-5-ht3-receptor-antagonis-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/antiemetic-prophylaxis-with-fosaprepitant-and-5-ht3-receptor-antagonis-peer-reviewed-article-DDDT

Similar Items